James is a partner and corporate lawyer who specialises in advising on complex cross-border business transactions, including M&A, IPOs, joint ventures, structured equity investments, venture capital and growth capital financing rounds.
James acts for clients all the way through the life cycle, including founders, growth companies, VC investors, institutions and listed companies (both LSE and Nasdaq), primarily in the technology and structured investment sectors.
James joined Taylor Wessing as a trainee in 2010.
Advised Allocate Software plc on its £109 million recommended takeover by Hg Capital.
Various pre-IPO funding rounds and IPOs, including for FDM Group, Attraqt Group, Creo Medical, Sphere Medical, Rezolve, Tritax Big Box and Boku.
Advising founders, companies and institutional investors on numerous venture and growth stage funding rounds, in the tech and life science sectors.
Advised Accel-KKR and the founders on the disposal of One.com to Cinven Private Equity.
Hilton Food Group plc on its class 1 acquisition of Icelandic SeaChill, funded by a underwritten placing and senior debt package.
by multiple authors
Advising Rezolve AI on its listing on NASDAQ
by Robert Fenner and James Homan
The new space race – outlook and opportunities in 2024
James Homan and Timo Stellpflug look at the investment landscape for 'New Space' technologies.
by James Homan and Timo Stellpflug
2 of 5 Insights
by multiple authors
by Wiebke Reuter, LL.M. (London) and Rita Fromm, Maître en droit
by multiple authors
by Jason Rawkins and Simon Jupp
by multiple authors
by Simon Jupp and Louise Popple
by multiple authors
by multiple authors
by multiple authors